Genus PLC - ESG Rating & Company Profile powered by AI
The assessment of Genus PLC is prepared by All Street Sevva using leading artificial intelligence. The Sustainability assessment for Genus PLC represents its transparency towards the UN Sustainable Development Goals. If you work at Genus PLC and you wish to use your Sustainability rating, please get in touch.
Genus PLC in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 7.2; made up of an environmental score of 8.0, social score of 5.7 and governance score of 8.0.
7.2
High ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 191 | Wockhardt Ltd | 7.3 | High |
| 191 | Zealand Pharma A/S | 7.3 | High |
| 217 | Genus PLC | 7.2 | High |
| 217 | Eurofins Scientific SE | 7.2 | High |
| 217 | Dermapharm Holding SE | 7.2 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Genus PLC have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Genus PLC disclose current and historical energy intensity?
Sign up for free to unlockDoes Genus PLC report the average age of the workforce?
Sign up for free to unlockDoes Genus PLC reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Genus PLC disclose its ethnicity pay gap?
Sign up for free to unlockDoes Genus PLC disclose cybersecurity risks?
Sign up for free to unlockDoes Genus PLC offer flexible work?
Sign up for free to unlockDoes Genus PLC have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Genus PLC disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Genus PLC conduct supply chain audits?
Sign up for free to unlockDoes Genus PLC disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Genus PLC conduct 360 degree staff reviews?
Sign up for free to unlockDoes Genus PLC disclose the individual responsible for D&I?
Sign up for free to unlockDoes Genus PLC disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Genus PLC disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Genus PLC disclose water use targets?
Sign up for free to unlockDoes Genus PLC have careers partnerships with academic institutions?
Sign up for free to unlockDid Genus PLC have a product recall in the last two years?
Sign up for free to unlockDoes Genus PLC disclose incidents of discrimination?
Sign up for free to unlockDoes Genus PLC allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Genus PLC issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Genus PLC disclose parental leave metrics?
Sign up for free to unlockDoes Genus PLC disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Genus PLC disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Genus PLC disclose the pay ratio of women to men?
Sign up for free to unlockDoes Genus PLC support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Genus PLC disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Genus PLC reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Genus PLC involved in embryonic stem cell research?
Sign up for free to unlockDoes Genus PLC disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Genus PLC disclose its waste policy?
Sign up for free to unlockDoes Genus PLC report according to TCFD requirements?
Sign up for free to unlockDoes Genus PLC disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Genus PLC disclose energy use targets?
Sign up for free to unlockDoes Genus PLC disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Genus PLC have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Genus PLC
These potential risks are based on the size, segment and geographies of the company.
Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells sows, boars, and semen to breed pigs with various characteristics for pork production under the PIC brand. The company also sells bull semen and embryos to breed calves with various characteristics for milk and beef production under the ABS, Genus, and Bovec brands. In addition, it offers semen sexing, in reproductive, and other technical services to farmers. Genus plc has a strategic collaboration with Beijing Capital Agribusiness Co. Ltd to pursue the porcine reproductive respiratory syndrome virus resistant regulatory and development work in China. The company was incorporated in 1994 and is based in Basingstoke, the United Kingdom.